Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.
PR Newswire, 810 Seventh Avenue, New York, NY 10019 - Tuesday October 21 8:31 AM EDT
"The addition of Canada to the growing list of countries where the female condom is available is consistent with our strategic objective of providing women around the world with this new and revolutionary option to protect themselves," said Dr. Mary Ann Leeper, President and Chief Operating Officer of The Female Health Company.
"The availability of the female condom in Canada will make a difference particularly to women, who are more susceptible to STDs than are men and, of course, more affected by unwanted pregnancies," added Dr. Marion Powell of Women's College Hospital and the Bay Centre for Birth Control in Toronto. "The fact is, some women and men can't use latex condoms and some men won't take responsibility for safer sex. Reality(R) gives women in these circumstances needed control over their sexual health and well-being."
Pharmascience is a Canadian-owned pharmaceutical manufacturer. According to IMS Canada figures, Pharmascience has been the fastest growing pharmaceutical company in Canada -- brand name or generic -- for the past three years. Since its founding in 1983 by two pharmacists, the firm has experienced compounded annual sales growth of 35% with current annual sales at approximately CA $70 million.
The Female Health Company, based in Chicago, owns certain worldwide rights to the female condom including patents which have been issued in the U.S., Japan, the European Union, The People's Republic of China, Canada, Brazil and Australia. The female condom is the only available product controlled by a woman that protects against sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy.
The female condom is in the early stages of global commercialization. It is currently marketed in the U.S., U.K., South Korea, Taiwan and Holland. As part of the United Nations Global Programme on AIDS (UNAIDS) it was recently launched in Zimbabwe. Further, The Female Health Company recently signed an agreement with a Brazilian partner which plans to launch the product in Brazil on December 1, 1997. The Company is in discussions with potential partners for India, The People's Republic of China, Europe, the U.S. and other countries.
SOURCE Female Health Company
Copyright (c) 1997/PR NewsWire. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Permissions Desk, PR Newswire, 810 Seventh Avenue, New York, NY 10019.
971021
PR971014
Copyright © 1997 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .